Pediatric Epilepsy Flashcards

1
Q

What is status epilepticus?

A

Medical emergency

Any recurrent or continuous seizure activity lasting over 30 minutes in which the patient does not regain baseline mental status

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

When is a seizure treated for status epilepticus?

A

Any seizure that does not stop within 5 minutes should be treated as impending status epilepticus

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What is given to patients to reduce risk of seizure progression to status epilepticus?

A

Midazolam intranasal or buccal

Injectable midazolam is given to kids via a nasal atomizer

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Why is midazolam preferred over diazepam for treatment of impending status epilepticus?

A

Midazolam has a shorter onset and offset of action

Midazolam also offers a reasonable recovery from sedative effects

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

How to use a nasal atomizer properly?

A

Can be reused if cost is an issue for families

Give quick push on syringe plunger

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What are epilepsy syndromes?

A

Refers to clusters of features that may occur together, including:
- Seizure type
- EEG findings
- Imaging findings
- Age-dependent features (ex. age at onset or remission)
- Specific comorbidities (ex. psychiatric illnesses)
- Triggers and sometimes prognosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What are some examples of epilepsy syndromes?

A

Childhood absence epilepsy

Juvenile absence epilepsy

Lennox-Gastaut Syndrome

Dravet syndrome

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What is the role of ethosuximide in treatment of seizures in children?

A

Narrow spectrum ASM

1st line for absence seizures (generally pediatric condition)

Not for any other seizure type (do not use as monotherapy if mixed seizure, even if absence seizures are a component)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What are the characteristics of absence seizures?

A

2-10 second episodes of blanking

If blanking lasts longer, then lower likelihood that the patient has absence seizures

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What are some advantages of using ethosuximide in children for seizures?

A
  • Lower rates of attention difficulties compared to valproate
  • Works quickly
  • Generally well-tolerated
  • Few drug interactions
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What are some disadvantages of using ethosuximide in children for seizures?

A

Narrow-spectrum of activity (only a good choice to use for uncomplicated absence seizures)

Does not confer protection for generalized tonic-clonic seizures

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What are some adverse effects associated with ethosuximide?

A

CNS effects (drowsiness, dizziness, behavioural changes)

GI effects (dose related, can divide dose to minimize)

Rare (blood dyscrasias, skin rashes)

Monitoring (CBC & platelets)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What is infantile epileptic spasms syndrome?

A

Epileptic spasms most often occur in “clusters” on awakening and involve tonic limb (+/-) head flexion or extension

Each spasm lasts less than 3 seconds, repeasts every 5-10 seconds for a period of 5 to 15 minutes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What does the EEG for a patient with infatile epileptic spasms syndrome look like?

A

May have a distinctive, disordered EEG pattern called hypsarrhythmia

May have psychomotor arrest

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What is the treatment strategy for infantile epileptic spasms syndrome?

A

Treat early and aggressively to prevent long-term sequelae (intellectual delays, refractory seizures)

Treatment options:
- Hormonal therapy (oral prednisolone)
- Vigabatrin
- other ASMs are ineffective

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What is MOA of vigabatrin?

A

Structural analog of GABA, but does not act on GABA receptors

MOA: irreversible inhibition of GABA-transaminase leads to increased GABA in the CNS = increased neuroinhibition

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

How long should vigabatrin be trialed if no clinical response?

A

If no clinical response in 7-14 days, change therapy

In most cases, switch to steroid

18
Q

What are some ADRs associated with vigabatrin?

A
  • Visual abnormalities, including permanent vision loss (black box warnings)
  • Vomiting and upper respiratory tract infections (more common in infants)
  • Asymptomatic MRI changes (resolves on d/c)
19
Q

What is Lennox-Gastaut Syndromes?

A

Developmental and epileptic encephalopathy with:
- Multiple drug-resistant seizure types (tonic, atonic, atypical absence, generalized tonic-clonic)
- Intellectual disability

The children with LGS may be medically complex with comorbid neurodevelopmental and behavioural disorders, sleep disorders, mobility requirements, feeding tubes

20
Q

Review slide 21 for treatment of Lennox-Gastaut Syndrome

A

According to NICE 2022 guidelines:

VPA: 1st line
Lamotrigine: 2nd line (monotherapy or adjunct)

21
Q

What is the official indication for rufinamide?

A

Only officially indicated for adjunct therapy in LGS for patients over four

22
Q

What are some ADRs associated with rufinamide?

A
  • Shortened QT interval (46-65%)
  • Headaches, drowsiness, dizziness
23
Q

What is Dravet Syndrome?

A

Drug-resistant developmental and epileptic encephalopathy
- Seizures of various types, often starting with early-onset febrile seizures in infancy
- Progressive cerebral and cerebellar atrophy
- Developmental delays and intellectual disability

24
Q

What is the prognosis of Dravet Syndrome?

A

Poor prognosis:
- Average life expectancy is about 9 years
- Historically (93% of deaths occur by age 20, associated with SUDEP)
- Earlier diagnosis and newer treatments are leading to 80% survival beyond 20 years

25
Q

Review slide 26 for a list of sodium channel blocking ASMs

26
Q

How is Dravet Syndrome treated?

A

Fenfluramine

Although CI in children, valproate + levocarnitine can be used if valproate therapy is absolutely necessary

Stiripentol

27
Q

What is the MOA of fenfluramine?

A

Not fully understood but may promote serotonin release, acts as a serotonin agonist, and inhibit serotonin transporters and reuptake

28
Q

What is the clinical efficacy of efficacy of fenfluramine?

A

Efficacy has been shown to be maintained out to 3 years and decreases risk of SUDEP and all cause mortality in Dravet Syndrome

29
Q

What are some concerns with using fenfluramine in children with Dravet Syndrome?

A

Pulmonary Arterial Hypertension and valvulopathy has not been described at anti-seizure doses

SIgnificant interaction with stiripentol (another drug used to treat Dravet Syndrome)

30
Q

What is the official indication for stiripentol in children?

A

Combined treatment with clobazam+valproate for refractory generalized tonic-clonic seizures in patients with Dravet Syndrome

31
Q

What are some ADRs associated with stiripentol?

A

Drowsiness (67%)
Agitation (27%)
Decreased appetite (45%)

Serious ADRs: Delirium, hallucinations

32
Q

What is the role of cannabinoids in treatment of seizures in children?

A

Not first line for any seizure disorder

FDA approval for seizures in LGS or Dravet syndrome for patients over 2 years old

50% reduction in convulsive seizure frequency vs. placebo (patients may experience 50-100 seizures per day, so 50% reduction is especially significant)

33
Q

What are some non-pharmacologcal therapy options for seizures in children?

A

Ketogenic diet

Surgery

Vagus Nerve Stimulation (VNS)

34
Q

What does a ketogenic diet look like for seizure prevention?

A

High fat, low carb diet (ketogenic)
- Requires strict compliance (CHO count includes drug excipients)
- Poorly tolerated (esp. in children)

May reduce seizure frequency (can be tried as adjunct if patient has experienced treatment failure

35
Q

What are some surgical options for reducing seizure frequency?

A

Not the first option considered

An option for some patients with refractory epilepsy (usually focal epilepsy)

Can either resect troublesome region or disconnect nerve fibers

Up to 70% of patients acheive seizure-freedom

36
Q

What is the role of vagus nerve stimulation in reducing seizure frequency in children?

A

Implant an electrical pulse generator and attach electrodes to the vagus nerve

Pulse generator stimulates vagus nerve on a regularly scheduled basis (MOA unknown)

Option in refractory focal onset or generalized seizures

Can take up to 1 to 1.5 years to see full benefit (patients still remain on ASMs)

37
Q

Review slides 37-42 for a pediatric epilepsy management case

38
Q

When are anti-seizure medications stopped?

A

Children with epilepsy often go into remission

Evidence supports stopping therapy after at least 2 years of seizure freedom

Consider ASM ADRs vs. risk of seizures when deciding to stop

39
Q

Review slide 44 for pediatric epilepsy pearls